Evaluating analytic models for individually randomized group treatment trials with complex clustering in nested and crossed designs
Many individually randomized group treatment (IRGT) trials randomly assign individuals to study arms but deliver treatments via shared agents, such as therapists, surgeons, or trainers. Post-randomization interactions induce correlations in outcome measures between participants sharing the same agent. Agents can be nested in or crossed with trial arm, and participants may interact with a single agent or with multiple agents. These complications have led to ambiguity in choice of models but there have been no systematic efforts to identify appropriate analytic models for these study designs. To address this gap, we undertook a simulation study to examine the performance of candidate analytic models in the presence of complex clustering arising from multiple membership, single membership, and single agent settings, in both nested and crossed designs and for a continuous outcome. With nested designs, substantial type I error rate inflation was observed when analytic models did not account for multiple membership and when analytic model weights characterizing the association with multiple agents did not match the data generating mechanism. Conversely, analytic models for crossed designs generally maintained nominal type I error rates unless there was notable imbalance in the number of participants that interact with each agent.
Authors
- David M. Murray (ORCID: https://orcid.org/0000-0003-0797-9269)
- Xueqi Wang (ORCID: https://orcid.org/0000-0001-9449-5451)
- Patrick J. Heagerty (ORCID: https://orcid.org/0000-0002-3403-6007)
- Andrea J. Cook (ORCID: https://orcid.org/0000-0002-6848-5222)
- Qilu Yu (ORCID: https://orcid.org/0000-0003-2641-3535)
- Jonathan Moyer
- Yunji Zhou (ORCID: https://orcid.org/0000-0002-3610-9257)
- Elizabeth L. Turner (ORCID: https://orcid.org/0000-0002-7638-5942)
- Fan Li (ORCID: https://orcid.org/0000-0001-6183-1893)
- Rui Wang (ORCID: https://orcid.org/0000-0001-5007-193X)
- Sherri Pals (ORCID: https://orcid.org/0000-0002-0003-6236)
Institutions
- Centers for Disease Control and Prevention (US)
- National Institutes of Health (US)
- Harvard University (US)
- Kaiser Permanente Washington Health Research Institute (US)
- Duke University (US)
- University of Washington (US)
- Yale University (US)
- National Center for Complementary and Integrative Health (US)
- Office of the Director (US)
- Harvard Pilgrim Health Care (US)
- Duke Institute for Health Innovation (US)
- Office of Disease Prevention (US)
Publication Details
- Journal
- Statistics in Medicine
- Published
- 2024-09-03
- DOI
- https://doi.org/10.1002/sim.10206
- Citations
- 6
- Primary Topic
- Statistical Methods in Clinical Trials
- Type
- article
- Field-Weighted Citation Impact
- 4.25